An Indirect Comparison Of Pembrolizumab Monotherapy Versus Ipilimumab Plus Nivolumab For First-Line Metastatic Nsclc With Pd-L1 Tps >= 1%
JOURNAL OF THORACIC ONCOLOGY(2021)
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined